Skip to main content
HR 4056 112th Congress House Health Drug safety, medical device, and laboratory regulation Federal preemption Government studies and investigations Intergovernmental relations Manufacturing Retail and wholesale trades State and local government operations

Science and Technology Regulatory Relief Act of 2012

Introduced: February 16, 2012 See on congress.gov
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 16, 2012
Referred to the House Committee on Energy and Commerce.
Feb 16, 2012
Introduced in House
 Plain-English summary Congressional Research Service

Science and Technology Regulatory Relief Act of 2012 - Amends the Federal Food, Drug, and Cosmetic Act to prohibit a state or political subdivision from conducting or requiring an inspection of a factory, warehouse, or establishment in which a drug or device is manufactured, processed, packed, or held by a manufacturer or wholesale distributor for introduction into interstate commerce, or after such introduction, for purposes of verifying compliance with such Act, Public Health Service Act requirements regarding the regulation of biological products, or any similar requirements established pursuant to state law.

Makes exceptions for such an inspection if: (1) the state or subdivision makes a determination that a drug or device presents a threat of serious adverse health consequences or death; (2) the Secretary of Health and Human Services (HHS) orders a recall of a drug, biological product, or device manufactured, processed, packed, or held at the factory, warehouse, or establishment; or (3) the Secretary requests or authorizes the state to conduct or require the inspection.

What's happening now February 16, 2012

Referred to the House Committee on Energy and Commerce.

 Committees of jurisdiction 1